3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Phase 2
1
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Melanoma
11
Neoplasm Metastasis
8
Prostatic Neoplasms
6
Triple Negative Breast Neoplasms
5
Multiple Myeloma
5
Lymphoma, Mantle-Cell
5
Lymphoma
5
Lung Neoplasms
5
Leukemia, Myeloid, Acute
4
Lymphoma, Large B-Cell, Diffuse
3
Leukemia, Myelomonocytic, Chronic
3
Leukemia, Biphenotypic, Acute
3
Hematologic Neoplasms
3
Fallopian Tube Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Burkitt Lymphoma
3
Waldenstrom Macroglobulinemia
2
Uterine Cervical Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Liposarcoma
2
Glioma
2
Cholangiocarcinoma
2
Carcinoma, Transitional Cell
2
Carcinoma, Renal Cell
2
Interventions
Ipilimumab
5
Nivolumab
4
pembrolizumab
3
sargramostim
2
fludarabine
2
binimetinib
2
aldesleukin
2
Interleukin-2
2
Granulocyte-Macrophage Colony-Stimulating Factor
2
Cyclophosphamide
2
trametinib
1
tebentafusp
1
sotrastaurin
1
montanide ISA 51
1
incomplete Freund's adjuvant
1
glembatumumab vedotin
1
fludarabine phosphate
1
entrectinib
1
Valproic Acid
1
Tramadol
1
Thalidomide
1
Temozolomide
1
Solutions
1
Ruthenium-106
1
Radiotherapy
1
RNA, Messenger
1
Protein Kinase C
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Ibuprofen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Uveal Melanoma
×
Biopsy
×
Clear all
NCT02654821
2018-11-02
TCR
The Netherlands Cancer Institute
Phase 1/2
Unknown
12 enrolled